Masimo Corp (NASDAQ:MASI) Institutional Investors Sentiment Index Increased in 2018 Q4

Masimo Corporation (NASDAQ:MASI) Logo

Sentiment for Masimo Corp (NASDAQ:MASI)

Masimo Corp (NASDAQ:MASI) institutional sentiment increased to 1.07 in Q4 2018. Its up 0.19, from 0.88 in 2018Q3. The ratio is positive, as 142 hedge funds started new and increased equity positions, while 133 decreased and sold their holdings in Masimo Corp. The hedge funds in our partner’s database reported: 44.42 million shares, up from 41.58 million shares in 2018Q3. Also, the number of hedge funds holding Masimo Corp in their top 10 equity positions decreased from 3 to 2 for a decrease of 1. Sold All: 22 Reduced: 111 Increased: 93 New Position: 49.

Masimo Corporation, a medical technology company, develops, makes, and markets noninvasive monitoring technologies worldwide. The company has market cap of $7.21 billion. The firm offers Masimo Signal Extraction Technology pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It has a 39.28 P/E ratio. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin saturation; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index.

The stock increased 0.27% or $0.37 during the last trading session, reaching $135.51. About 126,972 shares traded. Masimo Corporation (NASDAQ:MASI) has risen 62.81% since April 11, 2018 and is uptrending. It has outperformed by 58.44% the S&P500.

Analysts await Masimo Corporation (NASDAQ:MASI) to report earnings on May, 1. They expect $0.75 EPS, 0.00 % or $0.00 from last year’s $0.75 per share. MASI’s profit will be $39.88 million for 45.17 P/E if the $0.75 EPS becomes a reality. After $0.83 actual EPS reported by Masimo Corporation for the previous quarter, Wall Street now forecasts -9.64 % negative EPS growth.

Scholtz & Company Llc holds 3.93% of its portfolio in Masimo Corporation for 42,075 shares. New Amsterdam Partners Llc Ny owns 92,783 shares or 3.28% of their US portfolio. Moreover, Healthcor Management L.P. has 2.32% invested in the company for 747,040 shares. The New Hampshire-based D L Carlson Investment Group Inc has invested 1.47% in the stock. Scout Investments Inc., a Missouri-based fund reported 545,828 shares.

Since January 1, 0001, it had 0 buys, and 8 selling transactions for $7.92 million activity.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Masimo Corporation (NASDAQ:MASI) Ratings Coverage

Ratings analysis reveals 100% of Masimo’s analysts are positive. Out of 6 Wall Street analysts rating Masimo, 6 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $120 while the high is $155. The stock’s average target of $139.83 is 3.19% above today’s ($135.51) share price. MASI was included in 8 notes of analysts from November 28, 2018. The stock has “Overweight” rating by PiperJaffray on Wednesday, December 19. Needham maintained the stock with “Buy” rating in Wednesday, March 13 report. BTIG Research maintained Masimo Corporation (NASDAQ:MASI) rating on Tuesday, February 19. BTIG Research has “Buy” rating and $137 target. The stock of Masimo Corporation (NASDAQ:MASI) has “Buy” rating given on Wednesday, February 27 by Stifel Nicolaus. The firm earned “Buy” rating on Wednesday, February 27 by Piper Jaffray. Needham maintained the shares of MASI in report on Wednesday, February 27 with “Buy” rating.

More notable recent Masimo Corporation (NASDAQ:MASI) news were published by: Nasdaq.com which released: “ABIOMED Impella Data Show Significant Rise in Survival Rates – Nasdaq” on April 05, 2019, also Nasdaq.com with their article: “Cardiovascular Systems Gains on Global Growth & Innovation – Nasdaq” published on March 14, 2019, Nasdaq.com published: “Here’s Why Investors Should Retain Accuray (ARAY) Stock Now – Nasdaq” on April 11, 2019. More interesting news about Masimo Corporation (NASDAQ:MASI) were released by: Nasdaq.com and their article: “Integer Holdings Gets Positive Outlook & B+ Rating From S&P – Nasdaq” published on April 01, 2019 as well as Nasdaq.com‘s news article titled: “Allscripts’ FollowMyHealth Partners Ephraim McDowell Health – Nasdaq” with publication date: March 26, 2019.

Masimo Corporation (NASDAQ:MASI) Institutional Positions Chart